[Significance of complex hemodynamic studies for the choice of therapy with the beta-adrenergic blocker, atenolol, and the calcium antagonist, procorum, in patients with ischemic heart disease].
Ulianova
K N
KN
Surovov
Iu A
IuA
Sedov
V P
VP
Sidorenko
B A
BA
D000368:Aged; D000369:Aged, 80 and over; D001262:Atenolol / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology*; D005711:Gallopamil / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008875:Middle Aged
D005711:Gallopamil; D001262:Atenolol
Znachenie kompleksnogo issledovaniia gemodinamiki dlia vybora terapii beta-adrenoblokatorom atenololom i antagonistom kal'tsiia prokorumom u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.